![]() |
|
Gemzar® in Combination with Carboplatin as Treatment for Women with Recurrent Ovarian Cancer March 13, 2006 Richard Gaynor, MD Vice President, Global Oncology
2006-4203-S1-02-01-EliLilly&Co.ppt - Search
combination
treatment
women
recurrent
ovarian
cancer
march
richard
global
... accordingly A second protocol to prove clinical benefit was required July 2000 ALZA submitted a second Phase IV draft protocol DOXIL® and carboplatin vs. carboplatin ...
carboplatin. The dosage for the chemo drug carboplatin is done using the area under the curve (AUC). The AUC refers to the area under the drug concentration x time curve ...
Patients with chemotherapy hypersensitivity; Example = A patient with ovarian CA allergic to carboplatin; a patient with B cell lymphoma hypersensitive ...
Cisplatin and its analogue : carboplatin oxaliplatin ; Antimetabolite : methotrexate 5-FU Fludarabine gemcitabine Ara-C
use of chemotherapy drug.ppt - Search
cisplatin
analogue
oxaliplatin
antimetabolite
methotrexate
fludarabine
gemcitabine
It was recommended that he receive 6 weeks of post-operative concurrent chemotherapy and radiation. His chemotherapy included carboplatin/ paclitaxel weekly x 6 ...
... GOG 218 Stage III* or IV, Ovarian, primary peritoneal, or fallopian tube cancer Activated: 9/26/05 Accrual goal: 1800 pts Primary end point: PFS Carboplatin ...
GOG 158: Carboplatin vs. Cisplatin Improvements in Primary Therapy: Intraperitoneal Therapy RANDOMIZE FIGO stage III epithelial ovarian or peritoneal cancer Optimal (<1 ...
Efficacy results from the randomised phase III OPTIMAL (CTONG 0802) study comparing first-line erlotinib versus carboplatin (CBDCA) plus gemcitabine (GEM), in Chinese ...
index.php?option=com_docman&task=doc_download&gid=52&Itemid= - Search
efficacy
results
randomised
phase
optimal
ctong
study
comparing
first-line
erlotinib
versus
chinese
Blood samples may not reflect action in tissues The Case of Carboplatin Cleared 70% by glomerular filtration Linear correlation: Cl and GFR AUC correlates with ...
Carboplatin: AUC=6, day 1 . Docetaxel: 75 mg/m 2, day 1. Cisplatin: 75 mg/m 2, day 1 . Cisplatin: 100 mg/m 2, day 1. Gemcitabine: 1000 mg/m 2, days 1, 8, 15
Adequate organ function ECOG 2 or less 7 days prior to randomisation Study Arms: Phase II Arm 1 Day 1:Paclitaxel 135 mg/m2 IV day 1 plus carboplatin AUC 5 (measured ...
Group A: Cetuximab 400 mg/m2 initial dose then 250 mg/m2 weekly + carboplatin (AUC 5, Day 1) or cisplatin (100 mg/m2 IV, Day 1) + 5-FU (1,000 mg/m2 IV, Days 1–4): 3 ...
Carboplatin . Gemcitabine . Carbo/Gem . Docetaxel/ Paclitaxel . E1 low. TS high . E1 high. TS low . E1 low. TS low . E1 high. TS high . Carboplatin . Pemetrexed . Carbo/Pem
RR CR MVAC 40-75% <20% Gemzar / Cisplatin 40-70% 5-15% Gemzar / Carboplatin 65% 5% Taxol / Carboplatin 20-40% Adjuvant chemotherapy Six randomised trials have ...
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or ...
... doxorubicin, liposomal doxorubicin) Cyclophosphamide Taxanes (paclitaxel, docetaxel) Antimetabolites (5-FU, capecitabine) Gemcitabine Vinorelbine Carboplatin/cisplatin ...
Breast-Cancer-Low.ppt - Search
liposomal
cyclophosphamide
taxanes
antimetabolites
vinorelbine
/cisplatin
Randomized phase III comparison of paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan, both followed by gefitinib, in patients (pts) with carcinoma of ...
Hodgkin`s- and Non-Hodgkin`s-Lymphoma Clinical phase II study of combined thermo-chemotherapy (whole body hyperthermia plus Melphalan, Ifosfamide, Carboplatin and ...
IPERTERMIA & RADIOTERAPIA.ppt - Search
s-lymphoma
clinical
combined
thermo-chemotherapy
whole
hyperthermia
Schema Gem/carbo (GC) (N = 258) Gemcitabine 1,000 mg/m2 IV d 1, 8 carboplatin AUC 2 IV d 1, 8 21-day cycles Study design: Multicenter, randomized, open-label Phase III ...
|
Hot Documents 251/00نصائح-للامتحانات normatiivisesti colocarlas solas-1974-download celf-4 1000330-1-1 ash_dust baggage cancer-gastrique |